Paul Riviere

Also affiliated with UC San Diego Health System, University of California San Diego

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 20 papers. Top paper: “Tumor mutational burden is not predictive of cytotoxic chemotherapy response”.

Tumor mutational burden is not predictive of cytotoxic chemotherapy response

OncoImmunology(2020)10.1080/2162402x.2020.1781997

N/A

0.989DataRank · unranked

17 citations

Paul Riviere, Aaron M. Goodman, Donald A. Barkauskas, Garrett M. Frampton, Razelle Kurzrock +1 more

High Tumor Mutational Burden Correlates with Longer Survival in Immunotherapy-Naïve Patients with Diverse Cancers

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-20-0161

N/A

0.700DataRank · unranked

105 citations

Aaron M. Goodman, Ryosuke Okamura, Donald A. Barkauskas, Theresa J. Whitchurch, Suzanna Lee +9 more

Racial and Ethnic Disparities in Perceived Healthcare Discrimination and Health Outcomes

Journal of General Internal Medicine(2025)10.1007/s11606-025-09627-y

N/A

0.373DataRank · unranked

11 citations

Kylie Morgan, Kieran Buckley, Paul Riviere, Carol Y. Ochoa, Leah N. Deshler +5 more

Higher tumor mutational burden and PD-L1 expression correlate with shorter survival in hematologic malignancies

Therapeutic Advances in Medical Oncology(2024)10.1177/17588359241273053

N/A

0.339DataRank · unranked

6 citations

Aaron Trando, Sean D. Thomas, Paul Riviere, Patrick J. Sakowski, Ethan S. Sokol +3 more

Reply to Equal access to health care reduces racial disparities in prostate cancer outcomes and Access and socioeconomic status play an important role in outcomes for African American patients with prostate cancer

Cancer(2020)10.1002/cncr.33064

N/A

0.241DataRank · unranked

4 citations

Brent S. Rose, Paul Riviere

Opioid tapering in older cancer survivors does not increase psychiatric or drug hospitalization rates

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad241

N/A

0.208DataRank · unranked

3 citations

Kylie Morgan, Leah Deshler, Xinyi Huang, Carla Marienfeld, Christopher J. Coyne +3 more

Cost-effectiveness analysis of stereotactic ablative radiotherapy in patients with oligometastatic cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.7085

N/A

0.104DataRank · unranked

1 citations

Christopher Straka, Lucas K. Vitzthum, Daniel Cherry, P.T. Courtney, Paul Riviere +2 more

Cost-Effectiveness Analysis of Stereotactic Ablative Radiation Therapy in Patients With Oligometastatic Cancer

International Journal of Radiation Oncology*Biology*Physics(2020)10.1016/j.ijrobp.2020.09.045

N/A

0DataRank · unranked

28 citations

Christopher Straka, P.T. Courtney, Lucas K. Vitzthum, Paul Riviere, James D. Murphy +1 more

Prognostic Utility of Pre- and Postoperative Circulating Tumor DNA Liquid Biopsies in Patients with Peritoneal Metastases

Annals of Surgical Oncology(2020)10.1245/s10434-020-08331-x

N/A

0DataRank · unranked

23 citations

Paul Riviere, Richard B. Lanman, Kaitlyn J. Kelly, Jula Veerapong, Andrew M. Lowy +2 more

Validation of an oncology‐specific opioid risk calculator in cancer survivors

Cancer(2020)10.1002/cncr.33410

N/A

0DataRank · unranked

1 citations

Lucas K. Vitzthum, Vinit Nalawade, Rishi Deka, Timothy Furnish, Loren K. Mell +4 more

Survival of African American and non‐Hispanic white men with prostate cancer in an equal‐access health care system

Cancer(2020)10.1002/cncr.32666

N/A

0DataRank · unranked

136 citations

Elaine Luterstein, Abhishek Kumar, Lucas K. Vitzthum, Rishi Deka, Reith Sarkar +7 more

Trends in short-term, long-term, and high-risk opioid use among older cancer patients.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.29_suppl.187

N/A

0DataRank · unranked

0 citations

Paul Riviere, Lucas K. Vitzthum, Vinit Nalawade, James D. Murphy, Mia Salans

Outcomes for Muscle-invasive Bladder Cancer with Radical Cystectomy or Trimodal Therapy in US Veterans

European Urology Open Science(2021)10.1016/j.euros.2021.05.009

N/A

0DataRank · unranked

35 citations

Daniel Cherry, P.T. Courtney, Vinit Nalawade, Nikhil V. Kotha, Paul Riviere +6 more

Impact of the VA opioid safety initiative on pain management for cancer patients.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.102

N/A

0DataRank · unranked

0 citations

Vinit Nalawade, Neil Panjwani, Paul Riviere, Timothy Furnish, Lewei Lin +4 more

Impacts of an Opioid Safety Initiative on US Veterans Undergoing Cancer Treatment

JNCI Journal of the National Cancer Institute(2022)10.1093/jnci/djac017

N/A

0DataRank · unranked

7 citations

Vinit Nalawade, Paul Riviere, Mallika Marar, Timothy Furnish, Lewei Lin +3 more

Psychiatric or Drug Hospitalizations in Older Cancer Survivors on Long-Term Opioids

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.06.1206

N/A

0DataRank · unranked

0 citations

K. Morgan, Leah N. Deshler, Michael Xiao Huang, Carla Marienfeld, Christopher J. Coyne +3 more

Role of ultraviolet mutational signature versus tumor mutation burden in predicting response to immunotherapy

Molecular Oncology(2020)10.1002/1878-0261.12748

N/A

0DataRank · unranked

62 citations

Amélie Boichard, Aaron M. Goodman, Paul Riviere, Huwate Yeerna, Pablo Tamayo +2 more

Quality of care at safety‐net hospitals and the impact on pay‐for‐performance reimbursement

Cancer(2020)10.1002/cncr.33137

N/A

0DataRank · unranked

20 citations

P.T. Courtney, Katie Bachand, Paige Sheridan, Paul Riviere, Zachary D. Guss +5 more

MHC-I genotype and tumor mutational burden predict response to immunotherapy

Genome Medicine(2020)10.1186/s13073-020-00743-4

N/A

0DataRank · unranked

115 citations

Andrea Castro, Rachel Marty Pyke, Ryosuke Okamura, Shumei Kato, Paul Riviere +7 more

Testosterone therapy does not increase the risks of prostate cancer recurrence or death after definitive treatment for localized disease

Prostate Cancer and Prostatic Diseases(2020)10.1038/s41391-020-0241-3

N/A

0DataRank · unranked

14 citations

Sunil Patel, J. Kellogg Parsons, Rishi Deka, Abhishek Kumar, John Einck +8 more